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a  b  s  t  r  a  c  t
BDNF  is an important  marker  of  neuronal  plasticity.  It  has  also  been  associated  with  pain processing.
Increased  BDNF  levels  are  observed  in chronic  pain  syndromes.  In order  to  understand  the  role  of  BDNF
associated  with  other  factors  such  as  gender  on  experimental  pain  we aimed  to determine  whether
experimental  heat  or pressure  pain  threshold  is  correlated  with  brain  derived  neurotrophic  factor  (BDNF)
level,  gender  and age.  Heat  pain  threshold  and  pressure  pain  threshold  were  measured  in 49  healthy
volunteers  (27  females).  The  multivariate  linear  regression  models  (on  heat  and  pressure  pain  thresholds)
revealed  a signiﬁcant  effect  of  gender  (p  =  0.001  for  both  models),  serum  BDNF  (p  < 0.004  for  both  models)
and  interaction  between  BDNF  and  gender  (<0.001  for  both  models).  In fact,  when  adjusting  for  BDNFain levels  and  age,  heat  and  pressure  pain  thresholds  were  signiﬁcantly  reduced  in women  as  compared
to  men  (p  <  0.001  for both  models).  These  effects  were  not  observed  when  gender  was  analyzed  alone.
These  ﬁnding  suggests  that experimental  heat  and  pressure  pain  threshold  is  gender-related  and  BDNF
dependent.  In fact  BDNF  has  a facilitatory  effect  on  pain  threshold  in females  but  has  an  opposite  effect
in  males;  supporting  the  notion  that  BDNF  is an  effect  modiﬁer  of the  gender  effects  on  pain  threshold
in  healthy  subjects.
. Introduction
Brain derived neurotrophic factor (BDNF) is an important
arker and modulator of neural activity and NMDA receptor
ependent neuronal plasticity in ascending and descending pain
ransmission pathways [23]. In animals, BDNF and its TrkB receptor
re increased in models of bladder inﬂammation and nerve injury
29,45]. In humans, increased BDNF levels are associated with pain
n chronic pancreatitis [51]. In addition, when neutralizing BDNF
y anti-BDNF antibody, or TrkB receptor, mechanical allodynia [50]
nd thermal hyperalgesia were relieved [8].
Furthermore, pain-related BDNF activity seems to be related to
ender. In rats BDNF appears to worsen visceral pain in females
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while the opposite effect in males is observed [21]. In addition,
in previous studies, BDNF was associated with a speciﬁc effect on
depression-like behavior in rats, suggesting that there may be a
sexual dimorphism in BDNF function [26]. Though there is evi-
dence of gender-speciﬁc BDNF effects in animals; it remains to be
determined whether similar mechanisms are observed in humans
specially when associated with pain modulation.
Gender effects of behavioral pain have been extensively docu-
mented. It is well known that females experience more pain than
male in various pain states [5,15,30]. For example, prevalence of
various visceral pain disorders, such as chronic pelvic pain and irri-
table bowel syndrome, is more prevalent in women than men  [5].
Similar effects have been demonstrated for experimental thermal
pain [6], electrical pain [44], mechanical pain [16,19], ischemic pain
[22] and in some types of chronic pain such as in ﬁbromyalgia
[12] and migraine [3,47]. Moreover, gender differences in per-
ceived pain to a standardized painful stimulus show that this pain
Open access under the Elsevier OA license.induces differential cortical activity in mid cingulate cortex [13],
prefrontal cortex, insula, and thalamus [31] indicating overall that
women  show increased activity across brain regions associated
with medial pain pathway processing. Because this pathway is
ience Letters 514 (2012) 62– 66 63
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Table 1
Characteristics of the sample (n = 49).
Male (n = 22) Female (n = 27) p
Age (years) 25.40 ± 5.37 27 ± 7.53 0.18
State-anxiety at baseline 20.98 ±  4.11 20.00 ±  4.13 0.55
Trait-anxiety 18.55 ± 3.96 18.57 ± 4.70 0.91
(
(L.C. Stefani et al. / Neurosc
hought to code for affective/motivational components of the pain
xperience [33,34], increased activity here supports the notion that
ender differences in perceived pain are attributable to an affective
state-sensitive) recoding of pain-related afferent signaling.
In  summary, previous evidence consistently supports the idea
hat BDNF contributes to the development and sustainability of var-
ous pain states due to its critical role in plasticity-related processes
n pain pathways, both at spinal and supraspinal levels [25]. Given
nimal data, BDNF may  also have differential gender effects in pain
rocessing in humans. We  therefore aim to investigate whether
here is a gender difference in experimentally induced heat and
ressure pain thresholds, and then determine whether these dif-
erences are explained by differences in BDNF levels.
.  Subjects and methods
The  study protocol was approved by the Ethics Committee
t the institution in which the work was carried out and was
onducted in accordance with the Declaration of Helsinki. All par-
icipants signed an informed consent form. Forty-nine healthy
olunteers (27 females) aged from 22 to 40 participated in this
tudy. We  excluded subjects with peripheral nervous system dis-
ases or any clinically relevant clinical condition and subjects
sing medication that could affect the sensory perception, such
s neuropsychotropics and analgesic drugs. Finally female sub-
ects were required to have normal menstrual cycles and were not
regnant.
.1. Dependent variables
The  dependent variables of interest were heat and pressure
ain thresholds. To assess thermal threshold, we  determined the
uantitative heat pain thresholds using the method of limits on
 computer Peltier based device thermode, size 30 mm  × 30 mm.
t was attached to the skin on the ventral aspect of the sub-
ects’ midforearm. After a trial-run to familiarize the volunteers
ith the procedures, we performed the test series. Subjects were
lways assessed by the same researcher, who systematically read
he instructions and explained the standardized experimental pro-
edure using a modiﬁed previously published protocol [37] for
uantitative sensory testing (QST) assessments.
The baseline temperature was set initially at 32 ◦C and was
ncreased at a rate of 1 ◦C/s, to a maximum at 52 ◦C. The participant
as asked to press a button as quickly as possible when stimula-
ion became warm or painful. Three assessments were taken with
n interstimulus interval of 40 s [42] and thresholds were calcu-
ated by taking the average temperature of the three assessments.
he position of the thermode was altered slightly between trials
although it remained on the left ventral forearm) to prevent either
ensitization or response suppression of cutaneous heat nocicep-
ors.
Pressure pain detection thresholds (PPDT) values were quan-
iﬁed using a Fisher’s pressure algometer with a surface area of
.0 cm2 (Pain Diagnostics and Thermography, Great Neck, NY). Prior
o the test trial, the subject was instructed to verbally report per-
eption of the pain onset. During the testing session, the tip of the
lgometer was applied over the tibial surface. The pressure was
radually increased at a rate of 1 kgf/s. The average values of PPT in
gf/cm2 (lb/cm2) of three successive readings taken at intervals of
–5 min  were used as outcome.Subjects were asked to say ‘stop’ immediately when a dis-
ernible sensation of pain, distinct from pressure or discomfort,
as felt. At this point, the experimenter immediately retracted the
lgometer [7]. The digital display continued to show the value of
ressure applied at the moment the algometer was  retracted.Depressive symptoms on Beck
inventory
3.35  ± 2.94 3.11 ± 2.99 0.91
2.2. Independent variables
a) The blood level of BDNF was one of the independent vari-
ables  of interest. Blood samples were collected from all subjects
before  the experiment. Blood samples were centrifuged in plas-
tic  tubes for 10 min  at 4500 × g at 4 ◦C, and serum was stored
at  −80 ◦C for hormone assays. Serum BDNF was  determined
using a ChemiKine BDNF Sandwich ELISA Kit, CYT306, Chemi-
con/Millipore, Billerica, MA,  USA. The lower detection limits
of  the kits is 7.8 pg/mL for BDNF. The other main independent
variable was  gender. We  also analyzed the effects of age in our
model.
b) Depressive symptoms were assessed by the Beck Depression
Inventory (BDI) [10].
(c) Anxiety was measured with the reﬁned version of the rash
analysis  of the State-Trait Anxiety Inventory (STAI), adapted to
Brazilian Portuguese [18].
2.3. Statistical analysis
To  compare the baseline parameters between genders we  use
t test for independent sample. Stepwise multiple linear regression
models were performed with heat and pressure pain thresholds
as dependent variables. An interaction term for gender vs. BDNF
was used to assess a possible effect modiﬁer of serum BDNF on the
relationship between gender and pain threshold. In order to ensure
normally distributed data, we did log transformation for BDNF. Data
were analyzed using STATA software (11.0 version, College Sta-
tion, TX, USA). P values less than 0.05 (2-tailed) were considered
signiﬁcant.
3. Results
Forty nine subjects participated in this study (27 females), see
baseline demographic and psychological characteristics in Table 1.
There were no statistically signiﬁcant differences in the baseline
variables between males and females.
Interestingly, when analyzing experimental pain in females
and males, there was  a small non-signiﬁcant difference between
groups. The mean ± standard deviation of pressure pain threshold
in males and females was  6.60 ± 1.93 and 6.38 ± 1.97, respectively;
while for heat pain threshold, it was 43.03 ± 3.08 and 42.25 ± 3.80,
respectively (Table 2).
We then ﬁtted a regression model to assess the relationship of
pain, gender and BDNF for both models. These models revealed
a signiﬁcant effect of gender (p = 0.001 for both models), serum
BDNF (p < 0.004 for both models) and interaction between BDNF
and gender (<0.001 for both models). In fact, when adjusting for
BDNF levels and age, heat and pressure pain thresholds were sig-
niﬁcantly reduced in women  as compared to men  (p < 0.001 for both
models). Age was  not signiﬁcant in both models.4. Discussion
The purpose of this study was to investigate whether pain mod-
ulation (experimental heat and pressure pain thresholds) is gender
64 L.C.  Stefani et al. / Neuroscience Letters 514 (2012) 62– 66
Table 2
Multivariate linear regression of the interaction between BDNF and pain thresholds by gender (n = 47).
Parameter  ˇ t p 95% CI
(A) Dependent variable: heat pain threshold
Serum BDNF ng (log) −16.40 5.38 0.004 (−27.27 to −5.54)
Gender −10.67  2.89 0.001 (−16.52 to −4.83)
Age  (years) 0.02 0.22 0.828 (−0.12 to 0.15)
Interaction 11.63 3.24 0.001 (5.09 to 18.16)
Heat  pain threshold vs. serum BDNF (log) by gender
Serum BDNF ng (log) in male (n = 22) −4.78 2.24 0.04 (−9.48 to −0.09)
Serum  BDNF ng (log) in female (n = 27) 6.82 2.17 0.004 (2.33 to 11.30)
(B)  Dependent variable: pressure pain threshold
Serum BDNF ng (log) −10.36 −3.42 0.001 (−16.47 to −4.24)
Gender  −6.07 −3.72 0.001 (−9.36 to −2.78)
Age  (years) −0.02 −0.04 0.97 (−0.08 to 0.08)
Interaction  5.93 1.82 0.0001 (3.24 to 10.60)
Pressure  pain threshold vs. serum BDNF (log) by gender
Serum  BDNF ng (log) in male −3.43 −1.34 0.02 (−6.25 to −0.60)
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ependent when controlled for BDNF levels. As expected, women
xperienced more pain than men  when exposed to painful stimu-
ations and adjusted to BDNF levels. These ﬁndings suggest that the
evel of serum BDNF is an important effect modiﬁer for the effects
f gender on experimental pain. Higher levels of BDNF were cor-
elated with higher pain thresholds in females and in inversely in
ales. It is important to emphasize that these data were obtained in
ealthy volunteers using an experimentally controlled acute pain
timulus.
The present ﬁndings support the notion that BDNF levels
ay be a neurobiological mechanism underlying the gender-
elated differences in pain thresholds. BDNF has emerged as a
ey mediator of synaptic plasticity, neuronal connectivity and
endritic arborization [20,24]. Together with other biological fac-
ors (ex. neurotransmitters, hormones and other neurotrophins),
DNF orchestrates mechanisms of neuronal plasticity and survival.
owever, in our cross-sectional design, our data only allow us
o hypothesize this cause–effect relationship. Further studies are
eeded to elucidate the possible mechanism implicated in this
esponse and to clarify the issue about the gender-speciﬁc rela-
ionship of BDNF on pain thresholds.
Accordingly, the effect of gender in the relationship between
DNF and pain threshold can be explained by the estrogen levels,
hich regulates the increase in BDNF mRNA in areas associ-
ted with nociceptive sensory processing such as hippocampus,
erebral cortex and spinal cord [2]. Therefore the relationship
etween gender and BDNF on pain threshold observed in this
tudy may  indirectly conﬁrm the role of the regulatory effect of
strogen in sensitization of central nervous system centers asso-
iated with nociceptive sensory processing. This hypothesis is
lausible, because the level of BDNF is regulated by the level of
strogen, which has co-analgesic effect. Furthermore estrogen reg-
lates opioid receptor density in several pain-related areas (PAG,
arabrachial nucleus (PBn)); that is signiﬁcantly lower in female
ats during proestrus (higher plasma estrogen) compared with
iestrus and metestrus phases or male rats [4]. In fact, short-
erm treatment with estrogen in ovariectomized rats decreases the
umber of opioid binding sites in the brain, decreasing the anal-
esic effects of morphine [32]. In addition, estrogen modulates the
otency of morphine by inﬂuencing G protein coupling [35].
In  response to sustained pain, men  had larger magnitudes of
-opioid system activation than women in the anterior thalamus,
entral basal ganglia, and amygdala [52]. This evidence demon-
trates that at equivalent levels of pain or stimulus, men  and women
iffer in the magnitude and direction of response of the -opioid1.18 0.007 (1.07 to 5.91)
system  across a wide neural network. Thus, opioid response to
pain might explain the opposite effect of BDNF in the relationship
between genders and pain threshold.
There may  be additional mechanisms to explain this ﬁnding.
Firstly, other hormones, such as testosterone may also explain these
differences as in the case of testosterone, this hormone may  protect
against the hyperactivity of hypothalamus pituitary–adrenal (HPA)
axis [39,49]; which may  be deregulated in stress response between
men and women  [49,50]. Also, pain may  activate difference neu-
ral circuitry in men  and women [11,17,38]. For instance, Naliboff
et al. demonstrated that while women  showed greater activation in
the ventromedial prefrontal cortex, right anterior cingulate cortex,
and left amygdala in response to a visceral stimulus; men  showed
greater activation of the right dorsolateral prefrontal cortex, insula,
and dorsal pons/periaqueductal gray [28].
Secondly, one can hypothesize that the gender-speciﬁc effects
of BDNF on the synaptic activity is at least in part due to the tempo-
ral summation of reﬂex responses to a greater extent than it does
withdrawal reﬂex threshold. This is consistent with current psy-
chophysical and electrophysiological data, which show that women
summate more easily than men  and thus tend to up-regulate
their central processing relays more readily [6,36,40,41,43]. In this
scenario, higher BDNF levels would amplify this response and
therefore be associated with more pain.
Thirdly, another factor to consider when studying gender differ-
ences in withdrawal reﬂex activity (and pain sensitivity in general)
is the cyclical ﬂuctuation of gonadal steroids during the menstrual
cycle. Indeed, Tassorelli et al. [48] recently found that pain sensi-
tivity and nociceptive ﬂexion responses increase during the luteal
as opposed to the follicular phase of the menstrual cycle. It is pos-
sible, therefore, that our female subjects’ reﬂex responses may be
different (and comparable to those of men) because they were not
all tested during their follicular phase. In this context, BDNF levels
could be a surrogate for menstrual hormonal variation.
Fourthly, according to a primate model, BDNF is a selective
marker of early adversity in the female gender and a higher level
is indicative of abnormal responses manifested as a depression-
like state. This increase in BDNF levels early on may contribute
to the generation of individual differences in stress neurocircuitry,
providing a substrate for altered vulnerability to depressive disor-
ders at adulthood [27]. Maladaptive or repeated activation of stress
responsive biological mediators, such as neurotrophins, may have
long-term inﬂuences on stress sensitivity at adulthood and increase
vulnerability for stress-related illnesses, including psychopathol-
ogy and changes in pain threshold.
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Taking into account that the luteal phase was  not controlled in
his study this is an important limitation of this study. However,
t is unlikely that the direction of the correlation between BDNF
nd pain threshold would be different even if we had controlled
enstrual phase. In addition, although a previous study showed
orrelation between pain threshold an menstrual cycle [9], this
elationship has not been conﬁrmed in a subsequent study in which
ain threshold was unchanged during both the follicular and luteal
hase of the menstrual cycle [19].
Nevertheless, future studies are needed to properly assess the
elative impact of ﬂuctuating status variables (ex. hormonal pro-
le) on the context of gender-related differences observed here.
lthough the design we used is not ideal to infer a direct causal rela-
ionship, it permits us investigate this interaction between BDNF
nd gender in pain threshold in controlled manner in order to
xclude the inﬂuence of several confounding factors observed in
linical situations, such as baseline pain, psychological factors, and
ffect of other analgesics. Our design allowed us to investigate this
nteraction in a semi-objective way, using thermal and pressure
timulus measures as opposed to using primarily subjective scales
1,14]. In summary, in this study, we found that the individual pain
hresholds were inﬂuenced by gender however when controlled for
DNF. Several factors may  explain these ﬁndings such as the effects
f estrogens on opioid activity, effects of other hormones such as
estosterone on pain processing. Finally the effects of gonadal hor-
ones on neuroplasticity including immediate and previous effects
hat may  take place during neural development may  explain our
esults as discussed above.
Other  limitations to this study should be considered. First, we
ound that age was not correlated with pain threshold. This incon-
ruence with previous studies may  be explained by the limited age
ange of our sample as we aimed to recruit a homogeneous sample
o reduce other sources of variability. Second, one should consider
hat a limitation of our data is that the pressure of the thermode was
ot controlled in any special way. This factor has been discussed to
e a potential confounder in similar pain measurement setups [46].
he strong relationships we observed suggest that slight pressure
ifferences would not signiﬁcantly affect position–temperature
elationships.
Overall, these ﬁndings show that the level of serum BDNF is
orrelated with pain threshold when differentiated by gender.
igher levels of BDNF were correlated with higher pain thresholds
n females and inversely in males. Further studies should assess
dditional variables that may  help to explain variability in pain
hreshold across healthy and also chronic pain subjects.
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